Literature DB >> 23195909

[Primary hyperparathyroidism].

G Maruani1, N Cornière, L Nicolet, S Baron, M Courbebaisse, S Renaud, P Houillier.   

Abstract

For the past 40 years, primary hyperparathyroidism has been recognized as a common endocrine disease which is, most often, "non-symptomatic", without the occurrence of nephrolithiasis or osteitis fibrosa cystica. Our knowledge in the pathophysiology has increased largely and diagnosis of primary hyperparathyroidism is usually easy. The only radical treatment is surgery and the surgical indications have been codified by several consensus conferences. For patients who do not undergo surgery, prolonged medical monitoring is needed.
Copyright © 2012. Published by Elsevier SAS.

Entities:  

Keywords:  Hormone parathyroïdienne; Hypercalcemia; Hypercalcémie; Lithiase rénale; Nephrolithiasis; Osteopathy; Ostéopathie; Parathyroid hormone

Mesh:

Substances:

Year:  2012        PMID: 23195909     DOI: 10.1016/j.revmed.2012.10.369

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  2 in total

1.  Multiple brown tumors in primary hyperparathyroidism.

Authors:  Chirihan Ayadi; Safae Lanjery; Hajar Andour; Farah Kamel; Hamza El Qandili; Mendes Papys; Laila Jroundi; Fatima Zahra Laamrani
Journal:  Radiol Case Rep       Date:  2022-09-09

2.  Primary Hyperparathyroidism in Sickle Cell Disease: An Unknown Complication of the Disease in Adulthood.

Authors:  Elsa Denoix; Charlène Bomahou; Lorraine Clavier; Jean-Antoine Ribeil; François Lionnet; Pablo Bartolucci; Marie Courbebaisse; Jacques Pouchot; Jean-Benoît Arlet
Journal:  J Clin Med       Date:  2020-01-22       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.